WO2005097161A2 - Gpe and g-2mepe, caffeine and alkanol for treatment of cns injury - Google Patents

Gpe and g-2mepe, caffeine and alkanol for treatment of cns injury Download PDF

Info

Publication number
WO2005097161A2
WO2005097161A2 PCT/US2005/010816 US2005010816W WO2005097161A2 WO 2005097161 A2 WO2005097161 A2 WO 2005097161A2 US 2005010816 W US2005010816 W US 2005010816W WO 2005097161 A2 WO2005097161 A2 WO 2005097161A2
Authority
WO
WIPO (PCT)
Prior art keywords
2mepe
alkanol
gpe
caffeine
caffeinol
Prior art date
Application number
PCT/US2005/010816
Other languages
French (fr)
Other versions
WO2005097161A3 (en
Inventor
James Grotta
Peter D. Gluckman
Original Assignee
Neuren Pharmaceuticals Limited
The University Of Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US55794004P priority Critical
Priority to US60/557,940 priority
Priority to US57262704P priority
Priority to US60/572,627 priority
Application filed by Neuren Pharmaceuticals Limited, The University Of Texas filed Critical Neuren Pharmaceuticals Limited
Publication of WO2005097161A2 publication Critical patent/WO2005097161A2/en
Publication of WO2005097161A3 publication Critical patent/WO2005097161A3/en

Links